(Q34522261)

English

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

object named as

Ulf de Faire

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1

object named as

Björn Dahlöf

0 references

Ole Lederballe-Pedersen

10

object named as

Ole Lederballe-Pedersen

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sverre E. Kjeldsen

3

object named as

Sverre E Kjeldsen

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Richard B Devereux

2

object named as

Richard B Devereux

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

14

object named as

Suzanne Oparil

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Stevo Julius

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Gareth Beevers

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Frej Fyhrquist

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Hans Ibsen

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Krister Kristiansson

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lars H Lindholm

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Markku S Nieminen

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Per Omvik

13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Hans Wedel

15

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

LIFE Study Group

16

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

359

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

9311

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

995-1003

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Left ventricular hypertrophy and angiotensin II antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved electrocardiographic diagnosis of left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

An updated coronary risk profile. A statement for health professionals.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908089-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(02)08089-3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34522261&oldid=2061776625"